All stock lists
Invitation Homes Inc. (New York Stock Exchange:INVH)
US · Delayed Price · Currency is USD
Real Estate · REIT - Residential
$26.65-$0.23 (-0.86%)
Market cap
$15.4B
Insider Score
Health Score
Analyst consensus
Listed since
Feb 1, 2017
Website
Insider Score
––Not scored
INVH Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
INVH analyst forecast
INVH analyst consensus
Moderate Buy8 ratings
Buy 6 Hold 2 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
INVH 12-month price target
$32.38+21.5% upsideaverage of 8 firms
$35.00High
$30.00Low
Best analysts covering INVH
- Wells Fargo100%success rate · +13.2% avg return · 2 calls
- Raymond James57%success rate · -0.9% avg return · 7 calls
- Barclays50%success rate · -0.8% avg return · 10 calls
- Keybanc50%success rate · +0.5% avg return · 6 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
INVH analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-11-03 |
| Wells Fargo | Overweight | $30.00 | +10.8% | Reiterated | 2026-10-19 | |
| Barclays | Overweight | $35.00 | +31.6% | Reiterated | 2026-10-14 | |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-10-13 |
| UBS | Buy | $31.00 | +17.1% | Reiterated | 2026-10-12 | |
| — | Mizuho | Outperform | — | — | Upgraded | 2026-09-21 |
| Scotiabank | Sector Perform | $30.00 | +4.8% | Reiterated | 2026-09-17 | |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-08-25 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-08-05 |
| Oppenheimer | Outperform | $33.00 | +8.6% | Reiterated | 2026-08-03 | |
| Barclays | Overweight | $33.00 | +26.2% | Reiterated | 2026-07-14 | |
| UBS | Buy | $35.00 | +32.5% | Reiterated | 2026-07-08 | |
| — | Wells Fargo | Overweight | — | — | Upgraded | 2026-06-24 |
| — | Mizuho | Neutral | — | — | Reiterated | 2026-06-17 |
| BMO Capital | Market Perform | $35.00 | +17.9% | Reiterated | 2026-06-15 | |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-06-01 |
| — | CFRA | Sell | — | — | Downgraded | 2026-05-28 |
| Scotiabank | Sector Perform | $31.00 | +11.2% | Reiterated | 2026-05-21 | |
| Raymond James | Outperform | $32.00 | +14.6% | Upgraded | 2026-05-18 | |
| Morgan Stanley | Equal Weight | $33.00 | +27.1% | Reiterated | 2026-03-09 | |
| — | Raymond James | Market Perform | — | — | Downgraded | 2026-02-27 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-02-25 |
| Oppenheimer | Outperform | $31.00 | +22.1% | Reiterated | 2026-02-24 | |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-02-20 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-02-20 |
| — | Mizuho | Neutral | — | — | Downgraded | 2026-01-08 |
| Barclays | Overweight | $36.00 | +18.0% | Reiterated | 2025-11-25 | |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-11-13 |
INVH earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-18 | $0.18 | $0.27 | $686.7M | $685.3M |
| 2026-04-29 | $0.18 | $0.26 | $689.9M | $734.1M |
| 2026-07-29 | $0.17 | $0.37 | $731.1M | $747.5M |
| 2026-10-28 | $0.18 | $0.27 | $742.5M | $731.3M |
| 2027-02-17Upcoming | $0.19 | — | $736.5M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.